Portfolio Manager Bill Hench talks about the significance of the current global technology buildout and its effects on his portfolios. The tech buildout has been composed of a number of different things, primarily artificial intelligence, autonomous driving, public/private clouds, and really, the birth of a semiconductor capital equipment group in China. We’re talking about whole […]
These tech stocks are rather unnoticed and they have tons of potential Deeply undervalued tech stocks are hard to find. Finding them requires that investors search for lesser-followed companies. Quite often, the under-the-radar stocks have low trading volume, are not well known in the markets and have a small market capitalization. Such unknown stocks may […]
With important catalysts coming up in 2017, these stocks could soon become triple-digit winners in your portfolio. Start building a well-diversified biotech portfolio with these four stocks. The overall biotech sector continues to be locked in a tight trading range, especially for such a high beta sector of the market. First quarter earnings reports for […]
Buying shares at these prices might look like a gift in six month’s time. With multiple catalysts to fuel share price growth on the horizon and a lot of good news not yet baked into the share price, now is a great time to get in. The fairy tale story for biotech investors is buying […]
One of the cheapest stocks in our Acquirer’s Multiple, Small & Micro Cap – Stock Screener is Goldfield Corp (NYSEMKT:GV). With a market cap around $136 million, few investors have ever heard of this great little micro-cap. Goldfield Corporation (Goldfield), is a leading provider of electrical construction and maintenance services in the energy infrastructure industry primarily in […]
If you’re looking for the hottest growth track in tech, think small Continued good news about the economy is starting to thaw parts of the market that have been quietly chugging along in recent years — especially in small-cap tech. For most of these stocks, the recovery began from rock-bottom levels last year. But as […]
As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio. Sentiment on the biotech sector early in 2017 sure has […]
With lower approval wait times and decreased regulations on the horizon, long-term investing opportunities in the biotech sector haven’t looked this great in over two years. Take a look at these three stocks in particular as they will reap the most reward from a streamlined FDA. After an approximate gain of 10% in February, the […]
The market is off to a much stronger start this year than the bloodbath equities were greeted with to begin 2016. Biotech, after a dismal 18 months of underperformance is no exception. Sentiment on this beaten down part of the market started to improve immediately after the unexpected election result in November. The specter of […]
Myriad factors are contributing to the decline in equities, yet these tech stocks are shaking it off U.S. equities are languishing on Wednesday as geopolitical uncertainty from President Trump’s immigration order to upcoming elections in Europe weigh on sentiment. While large-cap stocks remain stable, the volatility and weakness is spreading in other assets from small-cap […]
If you want to invest successfully in one of the few sectors where 1,000% gains are anything but unusual, follow these three “golden rules” that Bret Jensen has developed over his decades-long career. The 45th President of the United States will be inaugurated this week and the stock market has started out 2017 on much […]
Free Report!
Simply sign up to receive our FREE Penny Stock Research newsletter and get immediate access to this report!
It's always 100% free and you can unsubscribe at any time.
